Sharemaestro company-news research for Meliá Hotels International, S.A. (MEL), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

MCE Spain Measured evidence

Company news sentiment

MEL news sentiment

Meliá Hotels International, S.A.

Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.

Weighted tone59Neutral is 50
Constructive news tone 46/100 evidence confidence 100% direct company focus 2 current stories across 1 publishers
Latest weekly closeEUR 10.17week of 7 Aug 2026
Dominant catalystEarnings75/100 classification confidence
News data statusHealthy0 duplicate stories removed

Current company news

Positive news being faded

Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.

Latest source headline CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong finance.yahoo.com · 07 Aug 2026 18:22

What supports the read

Direct evidence

2 current stories are mapped specifically to MEL.

Narrative agreement

Cross-story agreement is 83/100, indicating a comparatively coherent tape.

What tempers the read

Source breadth

Only 1 publisher currently contribute to the measured read.

Price disagreement

Constructive headlines are not being rewarded by price, which raises a rejection flag.

59/100
Weighted toneConstructive news tone
46/100
Evidence confidencebuilding confidence
100%/100
Company focus2 direct stories
83/100
Evidence agreement17/100 dispersion

News history

Tone and story flow over 21 days

Daily weighted evidence
07 Aug: 2 stories 07 Aug: tone 70, 2 stories 95505
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50

Evidence confidence

What supports the score

Measured separately from tone

Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.

Sample depth24
1.89 effective stories
Source breadth20
1 independent publishers
Direct relevance100
company-specific evidence share
Freshness39
recency-weighted evidence
Agreement83
cross-story consistency
Source independence0
lower publisher concentration

Price context

Sentiment against the 26-week price path

Positive news being faded

Constructive headlines are not being rewarded by price, which raises a rejection flag.

13 Feb 2026: close 7.88, indexed 100.020 Feb 2026: close 8.11, indexed 102.927 Feb 2026: close 8.34, indexed 105.806 Mar 2026: close 8.02, indexed 101.813 Mar 2026: close 8.56, indexed 108.620 Mar 2026: close 9.0, indexed 114.227 Mar 2026: close 9.45, indexed 119.903 Apr 2026: close 9.96, indexed 126.410 Apr 2026: close 10.76, indexed 136.517 Apr 2026: close 11.51, indexed 146.124 Apr 2026: close 11.36, indexed 144.201 May 2026: close 11.11, indexed 141.008 May 2026: close 11.31, indexed 143.515 May 2026: close 11.8, indexed 149.722 May 2026: close 11.46, indexed 145.429 May 2026: close 11.23, indexed 142.505 Jun 2026: close 10.81, indexed 137.212 Jun 2026: close 11.41, indexed 144.819 Jun 2026: close 12.26, indexed 155.626 Jun 2026: close 12.09, indexed 153.503 Jul 2026: close 11.83, indexed 150.110 Jul 2026: close 11.16, indexed 141.617 Jul 2026: close 10.59, indexed 134.424 Jul 2026: close 10.44, indexed 132.531 Jul 2026: close 10.34, indexed 131.207 Aug 2026: close 10.17, indexed 129.1 21 Jun 2026: sentiment 5421 Jun 2026: sentiment 5422 Jun 2026: sentiment 5522 Jun 2026: sentiment 5222 Jun 2026: sentiment 5223 Jun 2026: sentiment 5327 Jun 2026: sentiment 5227 Jun 2026: sentiment 5128 Jun 2026: sentiment 5130 Jun 2026: sentiment 5230 Jun 2026: sentiment 5003 Jul 2026: sentiment 5403 Jul 2026: sentiment 5303 Jul 2026: sentiment 5304 Jul 2026: sentiment 5309 Jul 2026: sentiment 5211 Jul 2026: sentiment 5712 Jul 2026: sentiment 5614 Jul 2026: sentiment 5815 Jul 2026: sentiment 5818 Jul 2026: sentiment 5818 Jul 2026: sentiment 5821 Jul 2026: sentiment 5821 Jul 2026: sentiment 5821 Jul 2026: sentiment 5822 Jul 2026: sentiment 5829 Jul 2026: sentiment 5230 Jul 2026: sentiment 5201 Aug 2026: sentiment 5302 Aug 2026: sentiment 5304 Aug 2026: sentiment 52
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price+29.1%latest close 10.17
Sentiment change-2available snapshot window
One-week response-1.6%Price digesting
Fair-value position+37.9%Materially above fair value
Sentiment confirms active trendPositive but stretched

News subjects

What is shaping the score

Earnings
Earnings702 stories · 100%

Source mix

Where the evidence comes from

0/100 independence
finance.yahoo.com702 stories · 100%

Recurring subjects

Subjects appearing most often

Current evidence
Earnings2Pharma1Net Income1Fourth Quarter1Fda Approval1Earnings Per Share1Earnings Growth1Defense1Clinical Trials1Biotech1

Earlier readings

How the score has changed

50 is the neutral baseline
ConstructiveBalanced or withheldCautious

Source headlines

The news behind the score

Showing 1-2 of 2

Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.

#148Tone
finance.yahoo.comDirect company coverage

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

Cytokinetics, Incorporated CYTK reported a second-quarter 2026 loss of $1.50 per share, narrower than the Zacks Consensus Estimate of a loss of $1.63 per share. In the year-ago quarter, the company reported a loss of $1.12 per share. Loss widened year over year due to higher SG&A expenses tied to costs associated with the commercial launch of Myqorzo and lower revenues. Revenues amounted to $28.6 million, which went down from $66.8 million in the year-ago quarter but surpassed the Zacks Consensus Estimate of $20 million. Cytokinetics' shares have surged 28.1% year to date compared with the ind

BiotechClinical TrialsEarningsFda ApprovalFourth QuarterPharma
Published
07 Aug 2026 18:22
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#284Tone
finance.yahoo.comDirect company coverage

Bittium Oyj (HLSE:BITTI) Earnings Reset The Valuation Debate

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. How Bittium Oyj's Latest Earnings Shape the Investment Picture Bittium Oyj (HLSE:BITTI) reported half year 2026 sales of €57.9 million and net income of €7.5 million, compared with €42.3 million and €1.5 million a year earlier, which sharpened investor focus on the stock. Those figures, together with basic earnings per share from continuing operations of €0.211 compared with €0.043 a year ago, provide fresh data to reassess

Balance SheetDefenseEarningsEarnings GrowthEarnings Per ShareNet Income
Published
07 Aug 2026 18:10
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated

How the page works

How to read the score

Tone is directional

It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

Classification, not prediction

The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.

Evidence context